Earnings Call · Q3 FY2022·2022-11-08

Q3 22EPS -3.85%·Rev n/aQ2 22EPS +5.66%·Rev n/aQ1 22EPS -10.64%·Rev n/aQ4 21EPS +4.26%·Rev n/a⚠ consensus missing

GLOBUS MEDICAL INC GMED

Brian Kearns — Unknown

Dan Scavilla — President and CEO

Keith Pfeil — Senior Vice President and Chief Financial Officer

−4.2%1d on move date−2.1% vs SPY3d+9.4%5d+11.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GMED calls or request research access.

More GMED calls Browse calls Request research access